Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 17
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Yin, Zhenyu Wu, Wenbo Liu, Renyuan Liang, Xue Yu, Tingting Chen, Xiaoling Feng, Jie Guo, Aibin Xie, Yu Yang, Haiyan Huang, Mingmin Tian, Chuanshuai Zhang, Bing and Xu, Yun 2015. APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D1H-MRS in non-demented elders. PeerJ, Vol. 3, p. e1202.

    Zamroziewicz, Marta K. Paul, Erick J. Rubin, Rachael D. and Barbey, Aron K. 2015. Anterior cingulate cortex mediates the relationship between O3PUFAs and executive functions in APOE e4 carriers. Frontiers in Aging Neuroscience, Vol. 7,

    Dixon, Roger A. DeCarlo, Correne A. MacDonald, Stuart W. S. Vergote, David Jhamandas, Jack and Westaway, David 2014. APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment. Frontiers in Aging Neuroscience, Vol. 6,

    Greenwood, Pamela M. Espeseth, Thomas Lin, Ming-Kuan Reinvang, Ivar and Parasuraman, Raja 2014. Longitudinal change in working memory as a function of APOE genotype in midlife and old age. Scandinavian Journal of Psychology, Vol. 55, Issue. 3, p. 268.

    Zhang, Chenan and Pierce, Brandon L. 2014. Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study. Neurobiology of Aging, Vol. 35, Issue. 6, p. 1512.e11.

    Ertekin-Taner, Nilüfer De Jager, Phillip L. Yu, Lei and Bennett, David A. 2013. Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease. Current Genetic Medicine Reports, Vol. 1, Issue. 1, p. 39.

    Jochemsen, Hadassa M. Muller, Majon van der Graaf, Yolanda and Geerlings, Mirjam I. 2012. APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study. Neurobiology of Aging, Vol. 33, Issue. 4, p. 832.e15.

    Adamson, Maheen M. Hutchinson, J. Benjamin Shelton, Amy L. Wagner, Anthony D. and Taylor, Joy L. 2011. Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE ɛ4 allele. Neuropsychologia, Vol. 49, Issue. 9, p. 2448.

    Tuminello, Elizabeth R. and Han, S. Duke 2011. The Apolipoprotein E Antagonistic Pleiotropy Hypothesis: Review and Recommendations. International Journal of Alzheimer's Disease, Vol. 2011, p. 1.

    Weiner, Myron Frederick Hynan, Linda Susan Rossetti, Heidi Warren, Matthew Wesley and Cullum, Colin Munro 2011. The relationship of montreal cognitive assessment scores to framingham coronary and stroke risk scores. Open Journal of Psychiatry, Vol. 01, Issue. 02, p. 49.

    Adamson, Maheen M. Landy, Kelly M. Duong, Susan Fox-Bosetti, Sabrina Ashford, J. Wesson Murphy, Greer M. Weiner, Michael and Taylor, Joy L. 2010. Apolipoprotein E ɛ4 influences on episodic recall and brain structures in aging pilots. Neurobiology of Aging, Vol. 31, Issue. 6, p. 1059.

    Calderón-Garcidueñas, Lilian Franco-Lira, Maricela Henríquez-Roldán, Carlos Osnaya, Norma González-Maciel, Angelica Reynoso-Robles, Rafael Villarreal-Calderon, Rafael Herritt, Lou Brooks, Diane Keefe, Sheyla Palacios-Moreno, Juan Villarreal-Calderon, Rodolfo Torres-Jardón, Ricardo Medina-Cortina, Humberto Delgado-Chávez, Ricardo Aiello-Mora, Mario Maronpot, Robert R. and Doty, Richard L. 2010. Urban air pollution: Influences on olfactory function and pathology in exposed children and young adults. Experimental and Toxicologic Pathology, Vol. 62, Issue. 1, p. 91.

    Kanaya, Kiyoshi Abe, Shine Sakai, Minoru Fujii, Hiroko and Iwamoto, Toshihiko 2010. Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: Relating to changes attributable to differences in apolipoprotein E phenotype. Geriatrics & Gerontology International, Vol. 10, Issue. 1, p. 25.

    Kim, Sang-Kyu Hwang, Tae-Yoon Lee, Kyeong-Soo Kang, Pock-Soo Cho, Hee-Soon and Bae, Young-Kyung 2009. Apolipoprotein E Polymorphism and Cognitive Function Change of the Elderly in a Rural Area, Korea. Journal of Preventive Medicine and Public Health, Vol. 42, Issue. 4, p. 261.

    Payton, Antony 2009. The APOE gene and cognitive function in non-demented and Alzheimer's disease patients. Reviews in Clinical Gerontology, Vol. 19, Issue. 03, p. 159.

    Woods, Diana Lynn Bushnell, Brittany Kim, Haesook Geschwind, Daniel and Cummings, Jeffrey 2009. Apolipoprotein 4 status is associated with behavioral symptoms in nursing home residents with dementia. International Psychogeriatrics, Vol. 21, Issue. 04, p. 722.

    Barba, Ignasi Fernandez-Montesinos, Rafael Garcia-Dorado, David and Pozo, David 2008. Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. Journal of Cellular and Molecular Medicine, Vol. 12, Issue. 5a, p. 1477.


Apolipoprotein E genotype and lifetime cognitive decline

  • Nicholas A. Kozauer (a1), Michelle M. Mielke (a2), Gary Kwun Chuen Chan (a3), George W. Rebok (a4) and Constantine G. Lyketsos (a5)
  • DOI:
  • Published online: 01 February 2008

Objective: The relationship of apolipoprotein E (APOE) genotype to lifetime cognitive decline was examined over 22 years in a large community-based population study.

Method: The sample for the present study was derived from follow-up of a probability sample of the adult household residents of East Baltimore. From the Baltimore cohort of the Epidemiologic Catchment Area Study, genotype data were collected on 818 participants at the study's fourth wave between 2003 and 2004. Participants were administered the Mini-mental State Examination (MMSE) at all four study waves. Three tests of verbal learning – immediate recall, delayed recall, and word recognition – were completed at waves 3 and 4. The 659 participants for whom genetic data were available had also completed cognitive testing at all time points. Test scores and changes in these scores were examined by APOE genotype group (x/x or 4/x) in younger and older subcohorts defined by age at wave 4 (< or ≥ age 65).

Results: Cross-sectional wave 4 scores on all four cognitive tasks were lower in APOEε4 carriers when compared to non-carriers. In longitudinal univariate models ε4 carriers in the younger cohort demonstrated a greater annual rate of decline on a delayed recall task and MMSE. After adjusting for covariates only the decline in the delayed recall task was significant.

Conclusion: We report an association between APOE genotype and decline in delayed recall and possibly MMSE over this extended time period limited to younger individuals. The lack of an association between APOE and decline in older individuals is likely to be the result of survival bias. Although a clear association exists between APOE genotype and cognitive decline or dementia in late life, these findings suggest that over the lifespan the relationship between APOE and cognitive decline is more complicated.

Corresponding author
Correspondence should be addressed to: Dr. Nicholas A. Kozauer, Division of Geriatric and Neuropsychiatry, Johns Hopkins School of Medicine, 550 N. Broadway, Suite 308, Baltimore, MD 21205. Phone +1 410 502 3748; Fax +1 410 614 8042. Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

L. C. Baxter , R. J. Caselli , S. C. Johnson , E. Reiman , D. Osborne 2003. Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiology of Aging, 24, 947952.

C. K. Blair 2005. APOE genotype and cognitive decline in a middle-aged cohort. Neurology, 64, 268276.

P. Bretsky , J. M. Guralnik , L. Launer , M. Albert , T. E. Seeman 2003. The role of APOE-ε4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 10771081.

R. Brookmeyer , S. Gray and C. Kawas 1998. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health, 88,13371342.

R. J. Caselli 1999. Preclinical memory decline in cognitively normal apolipoprotein E- ε4 homozygotes. Neurology, 53, 201207.

R. M. Cohen , C. Small , F. Lalonde , J. Friz and T. Sunderland 2001. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57, 22232228.

A. Collie 2001. Memory decline in healthy older people: implications for identifying mild cognitive impairment. Neurology, 56, 15331538.

E. H. Corder 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921923.

E. H. Corder 1994 Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180184.

M. G. Dik , C. Jonker , L. M. Bouter , M. I. Geerlings , G. J. van Kamp and D. J. Deeg 2000. APOE-ε4 is associated with memory decline in cognitively impaired elderly. Neurology, 54, 14921497.

W. W. Eaton and L. G. Kessler 1985. Epidemiologic Field Methods in Psychiatry: The NIMH Epidemiologic Catchment Area Program. Orlando, FL: Academic Press.

W. W. Eaton 1997. Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Archives of General Psychiatry, 54, 993999.

E. J. Feskens , L. M. Havekes , S. Kalmijn , P. de Knijff , L. J. Launer and D. Kromhout 1994. Apolipoprotein ε4 allele and cognitive decline in elderly men. BMJ, 309, 12021206.

G. G. Fillenbaum , L. R. Landerman , D. G. Blazer , A. M. Saunders , T. B. Harris and L. J. Launer 2001. The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. Journal of the American Geriatrics Society, 49, 11481155.

M. F. Folstein , S. E. Folstein and P. R. McHugh 1975. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.

T. Gomez-Isla 1996 Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Annals of Neurology, 39, 6270.

E. L. Helkala 1996 Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neuroscience Letters, 204, 177180.

B. T. Hyman 1996. Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease. Journal of the American Geriatrics Society, 44, 14691471.

C. Jonker , B. Schmand , J. Lindeboom , L. M. Havekes and L. J. Launer 1998. Association between apolipoprotein E ε4 and the rate of cognitive decline in community dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 10651069.

J. H. Kang , G. Logroscino , I. De Vivo , D. Hunter and F. Grodstein 2005. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiology of Aging, 26, 475484.

A. S. Khachaturian , C. D. Corcoran , L. S. Mayer , P. P. Zandi and J. C. Breitner 2004. Cache County Study Investigators. Apolipoprotein E ε4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry, 61, 518524.

L. Kuller 1998. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke, 29, 388398.

C. Lahoz 2001. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis, 154, 529537.

N. M. Laird and J. H. Ware 1982. Random-effects models for longitudinal data. Biometrics, 38, 963974.

R. Mayeux , S. A. Small , M. Tang , B. Tycko and Y. Stern 2001. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683689.

M. O. McCarron , D. Delong and M. J. Alberts 1999. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology, 53, 13081311.

E. L. Mortensen and P. Hogh 2001. A gender difference in the association between APOE genotype and age-related cognitive decline, Neurology, 57, 8995.

R. O'Hara , J. A. Yesavage , H. C. Kraemer , M. Mauricio , L. F. Friedman and G. M. Jr. Murphy 1998 The APOE ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults. Journal of the American Geriatrics Society, 46, 14931498.

T. G. Ohm , M. Kirca , J. Bohl , H. Scharnagl , W. Gross and W. Marz 1995. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience, 66, 583587.

T. Pirttila 1997. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiology of Aging, 18, 121127.

T. Polvikoski 1995. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. The New England Journal of Medicine, 333, 12421247.

K. P. Riley , D. A. Snowdon , A. M. Saunders , A. D. Roses , J. A. Mortimer and N. Nanayakkara 2000 Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. Journals of Gerontology Series B: Biological Sciences and Medical Sciences, 55, S69S75.

L. N. Robins , J. E. Helzer , J. Croughan and K. Ratcliff 1981 National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Archives of General Psychiatry, 38, 381389.

A. M. Saunders 1993. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 14671472.

D. L. Sparks 1997. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Annals of the New York Academy of Science, 826, 128146.

J. H. Stengard , K. M. Weiss and C. F. Sing 1998. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Human Genetics, 103, 234241.

P. H. George-Hyslop St. 2000. Genetic factors in the genesis of Alzheimer's disease. Annals of the New York Academy of Science, 924, 17.

C. Talbot , C. Lendon , N. Craddock , S. Shears , J.C. Morris and A. Goate 1994. Protection against Alzheimer's disease with apoE ε2. Lancet, 343, 14321433.

T. N. Tombaugh and N. J. McIntyre 1992. The mini-mental state examination: a comprehensive review. Journal of the American Geriatrics Society, 40, 922935.

P. W. Wilson , E. J. Schaefer , M. G. Larson and J. M. Ordovas 1996. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 12501255.

R. S. Wilson 2002. The apolipoprotein ε 4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59, 11541160.

M. Winnock , L. Letenneur , H. Jacqmin-Gadda , J. Dallongeville , P. Amouyel and J. F. Dartigues 2002. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. Journal of Neurology, Neurosurgery, and Psychiatry, 72, 794797.

K. Yaffe , J. Cauley , L. Sands and W. Browner 1997. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology, 54, 11101114.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *